4.6 Article

Population Pharmacokinetics of Intranasal Dexmedetomidine in Infants and Young Children

Related references

Note: Only part of the references are listed.
Article Anesthesiology

Pharmacokinetics and Pharmacodynamics of 3 Doses of Oral-Mucosal Dexmedetomidine Gel for Sedative Premedication in Women Undergoing Modified Radical Mastectomy for Breast Cancer

Sahar Abdel-Baky Mohamed et al.

Summary: This study compared the pharmacokinetic and pharmacodynamic properties of different doses of buccal DEX gel in female patients undergoing modified radical mastectomy for breast cancer. The results showed that the 1 µg/kg dose of buccal DEX gel produced early postoperative sedation, lower heart rate values, and dose-dependent postoperative analgesia. Administering DEX formulated as an oral-mucosal gel sublingually 60-120 minutes before surgery may provide a safe and practical means of sedative premedication in adults.

ANESTHESIA AND ANALGESIA (2021)

Article Pharmacology & Pharmacy

Off-label use of dexmedetomidine in paediatric anaesthesiology: an international survey of 791 (paediatric) anaesthesiologists

Camille E. van Hoorn et al.

Summary: This international study investigated the prescribing practices of dexmedetomidine by paediatric anaesthesiologists. The results showed that there were large intercontinental differences in prescribing dexmedetomidine, calling for consensus and worldwide education on the optimal use in paediatric practice.

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2021)

Article Pharmacology & Pharmacy

Target-controlled infusion of dexmedetomidine effect-site concentration for sedation in patients undergoing spinal anaesthesia

Kyung Mi Kim et al.

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2020)

Article Pharmacology & Pharmacy

Dose rationale and pharmacokinetics of dexmedetomidine in mechanically ventilated new-borns: impact of design optimisation

Sven C. van Dijkman et al.

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2019)

Article Pharmacology & Pharmacy

Pharmacokinetics of Intranasally Administered Dexmedetomidine in Chinese Children

Cheng-Yu Wang et al.

FRONTIERS IN PHARMACOLOGY (2019)

Article Anesthesiology

Pharmacokinetic and pharmacodynamic study of intranasal and intravenous dexmedetomidine

A. Li et al.

BRITISH JOURNAL OF ANAESTHESIA (2018)

Article Pharmacology & Pharmacy

Scaling clearance in paediatric pharmacokinetics: All models are wrong, which are useful?

Eva Germovsek et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2017)

Article Pharmacology & Pharmacy

Allometric Scaling of Clearance in Paediatric Patients: When Does the Magic of 0.75 Fade?

Elisa A. M. Calvier et al.

CLINICAL PHARMACOKINETICS (2017)

Review Multidisciplinary Sciences

Interpatient Variability in Dexmedetomidine Response: A Survey of the Literature

Samantha F. Holliday et al.

SCIENTIFIC WORLD JOURNAL (2014)

Article Pharmacology & Pharmacy

Handling Data Below the Limit of Quantification in Mixed Effect Models

Martin Bergstrand et al.

AAPS JOURNAL (2009)

Review Urology & Nephrology

Measurement and Estimation of GFR in Children and Adolescents

George J. Schwartz et al.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)

Article Anesthesiology

Dexmedetomidine pharmacokinetics in pediatric intensive care - a pooled analysis

Amanda L. Potts et al.

PEDIATRIC ANESTHESIA (2009)

Review Pharmacology & Pharmacy

Mechanism-based concepts of size and maturity in pharmacokinetics

B. J. Anderson et al.

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2008)

Article Pharmacology & Pharmacy

Likelihood based approaches to handling data below the quantification limit using NONMEM VI

Jae Eun Ahn et al.

JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2008)

Article Anesthesiology

Dexmedetomidine disposition in children: a population analysis

Amanda L. Potts et al.

PEDIATRIC ANESTHESIA (2008)

Article Pharmacology & Pharmacy

Bioavailability of dexmedetomidine after extravascular doses in healthy subjects

M Anttila et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2003)